Literature DB >> 9126476

Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse Fgfr3 gene.

A V Perez-Castro1, J Wilson, M R Altherr.   

Abstract

Fibroblast growth factor receptor 3 (FGFR3) is a developmentally regulated transmembrane protein. Three other FGFRs (1, 2, and 4) in conjunction with FGFR3 are part of the receptor tyrosine kinase super-family. Mutations in three of these genes (FGFR1, 2, and 3) have been determined to be the cause of human growth and developmental disorders. We have characterized a 22-kb DNA fragment containing the human FGFR3 gene and determined 11 kb of its nucleotide sequence. The gene consists of 19 exons and 18 introns spanning 16.5 kb, and the boundaries between exons and introns follow the GT/AG rule. The translation initiation and termination sites are located in exon 2 and exon 19 respectively. The sequence of the 5'-flanking region (1.5 kb) lacks the typical TATA or CAAT boxes. However, several putative binding sites for transcription factors SP1, AP2, Krox 24, IgHC.4, and Zeste are present. The 0.77-kb region from position -889 (5'-flanking region) to -119 (intron 1) contains a CpG island. A comparative sequence analysis of the human and mouse FGFR3 genes indicates that the overall genomic structure and organization of the human gene are nearly identical to those of its mouse counterpart. Furthermore, there is a striking similarity in the promoter regions of both genes, and several of the putative transcription factor-binding sites are conserved across species, suggesting a definitive role of these factors in the transcriptional regulation of these genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126476     DOI: 10.1006/geno.1997.4616

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

Authors:  Xing Ai; Zhuo-Min Jia; Juan Wang; Gui-Ping DI; X U Zhang; Fengling Sun; Tong Zang; Xiumei Liao
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

Review 2.  Advances in research on and diagnosis and treatment of achondroplasia in China.

Authors:  Yao Wang; Zeying Liu; Zhenxing Liu; Heng Zhao; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2013-05

3.  Genomic structure and complete sequence of the human FGFR4 gene.

Authors:  M Kostrzewa; U Müller
Journal:  Mamm Genome       Date:  1998-02       Impact factor: 2.957

4.  Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors.

Authors:  N Funato; K Ohtani; K Ohyama; T Kuroda; M Nakamura
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

5.  A novel isoform of human fibroblast growth factor 8 is induced by androgens and associated with progression of esophageal carcinoma.

Authors:  S Tanaka; H Ueo; K Mafune; M Mori; J R Wands; K Sugimachi
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

6.  Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis.

Authors:  Sahan V Rannan-Eliya; Indira B Taylor; I Marieke De Heer; Ans M W Van Den Ouweland; Steven A Wall; Andrew O M Wilkie
Journal:  Hum Genet       Date:  2004-07-07       Impact factor: 4.132

7.  Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.

Authors:  Rajini Parakati; Joseph X DiMario
Journal:  J Biol Chem       Date:  2013-04-08       Impact factor: 5.157

Review 8.  Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?

Authors:  Christine Heinzle; Zeynep Erdem; Jakob Paur; Bettina Grasl-Kraupp; Klaus Holzmann; Michael Grusch; Walter Berger; Brigitte Marian
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

9.  Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.

Authors:  Li Zhou; Lu-Tian Yao; Zhi-Yong Liang; Wei-Xun Zhou; Lei You; Qian-Qian Shao; Shuai Huang; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.

Authors:  Yongdong Jiang; Shanshan Sun; Wei Wei; Yanlv Ren; Jing Liu; Da Pang
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.